Agile Therapeutics
(NASDAQ:AGRX)
$0.91
-0.0822[-8.28%]
At close: Feb 22
$0.91
0[0.00%]
After Hours: 6:08PM EDT

GET A REPORT ON AGRX SENT RIGHT TO YOUR INBOX

Agile Therapeutics Stock (NASDAQ:AGRX), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Buy
Highest Price Target1
$12.00
Lowest Price Target1
$5.00
Consensus Price Target1
$5.50

Analyst Rating Summary1

Analyst Ratings
Sep 23
1
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Maxim Group
HC Wainwright & Co.
RBC Capital

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Agile Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
09/22/2023AGRXBuy Now
Agile Therapeutics
$0.91449.45%Maxim Group
Naz Rahman
→ $5UpgradeHold → BuyGet Alert
06/26/2023AGRXBuy Now
Agile Therapeutics
$0.911218.68%HC Wainwright & Co.
Oren Livnat
→ $12ReiteratesBuy → BuyGet Alert
06/07/2023AGRXBuy Now
Agile Therapeutics
$0.911218.68%HC Wainwright & Co.
Oren Livnat
→ $12ReiteratesBuy → BuyGet Alert
12/30/2022AGRXBuy Now
Agile Therapeutics
$0.91229.67%HC Wainwright & Co.
Oren Livnat
$250 → $150MaintainsBuyGet Alert
07/26/2022AGRXBuy Now
Agile Therapeutics
$0.919.89%Maxim Group
Naz Rahman
→ $50UpgradeHold → BuyGet Alert
07/11/2022AGRXBuy Now
Agile Therapeutics
$0.91449.45%HC Wainwright & Co.
Oren Livnat
$125 → $250MaintainsBuyGet Alert
04/08/2022AGRXBuy Now
Agile Therapeutics
$0.91Maxim Group
Caroline Palomeque
DowngradeBuy → HoldGet Alert
11/03/2021AGRXBuy Now
Agile Therapeutics
$0.91174.73%HC Wainwright & Co.
Oren Livnat
MaintainsBuyGet Alert
09/13/2021AGRXBuy Now
Agile Therapeutics
$0.91284.62%HC Wainwright & Co.
Oren Livnat
MaintainsBuyGet Alert
07/27/2021AGRXBuy Now
Agile Therapeutics
$0.91449.45%RBC Capital
Daniel Busby
MaintainsOutperformGet Alert

FAQ

Q

What is the target price for Agile Therapeutics (AGRX)?

A

The latest price target for Agile Therapeutics (NASDAQ: AGRX) was reported by Maxim Group on September 22, 2023. The analyst firm set a price target for $5.00 expecting AGRX to rise to within 12 months (a possible 449.45% upside). 3 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Agile Therapeutics (AGRX)?

A

The latest analyst rating for Agile Therapeutics (NASDAQ: AGRX) was provided by Maxim Group, and Agile Therapeutics upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Agile Therapeutics (AGRX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Agile Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Agile Therapeutics was filed on September 22, 2023 so you should expect the next rating to be made available sometime around September 22, 2024.

Q

Is the Analyst Rating Agile Therapeutics (AGRX) correct?

A

While ratings are subjective and will change, the latest Agile Therapeutics (AGRX) rating was a upgraded with a price target of $0.00 to $5.00. The current price Agile Therapeutics (AGRX) is trading at is $0.91, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch